Clinical trial
Comparing Therapies for the Treatment of Severe Aplastic Anemia
NCT00001626 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00001626 |
|---|---|
| Title | Comparing Therapies for the Treatment of Severe Aplastic Anemia |
| Official title | A Randomized Trial of Antithymocyte Globulin and Cyclosporine Versus Cyclophosphamide and Cyclosporine in the Treatment of Severe Aplastic Anemia |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Severe Aplastic Anemia (SAA) |
| Intervention type | Drug |
| Interventions | antithymocyte globulin, cyclophosphamide, cyclosporine |
| Enrollment | 33 |
| Start date | Jun 2, 1997 |
| Primary completion | Feb 20, 2001 |
| Completion | Mar 3, 2008 |
| First posted | Nov 4, 1999 |
| Last update posted | Sep 22, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: